TY - JOUR
T1 - Class IA PI3Ks regulate subcellular and functional dynamics of IDO1
AU - Iacono, Alberta
AU - Pompa, Andrea
AU - De Marchis, Francesca
AU - Panfili, Eleonora
AU - Greco, Francesco A.
AU - Coletti, Alice
AU - Orabona, Ciriana
AU - Volpi, Claudia
AU - Belladonna, Maria L.
AU - Mondanelli, Giada
AU - Albini, Elisa
AU - Vacca, Carmine
AU - Gargaro, Marco
AU - Fallarino, Francesca
AU - Bianchi, Roberta
AU - De Marcos Lousa, Carine
AU - Mazza, Emilia M. C.
AU - Bicciato, Silvio
AU - Proietti, Elisa
AU - Milano, Francesca
AU - Martelli, Maria P.
AU - Iamandii, Ioana M.
AU - Graupera Garcia-Mila, Mariona
AU - Llena Sopena, Judith
AU - Hawkins, Phillip
AU - Suire, Sabine
AU - Okkenhaug, Klaus
AU - Stark, Anne Katrien
AU - Grassi, Fabio
AU - Bellucci, Michele
AU - Puccetti, Paolo
AU - Santambrogio, Laura
AU - Macchiarulo, Antonio
AU - Grohmann, Ursula
AU - Pallotta, Maria T.
N1 - Funding Information:
This work was supported by the European Research Council (338954-DIDO; to UG and AM), Associazione Italiana per la Ricerca sul Cancro (AIRC 2019-23084 to UG), and by Ministero dell'Istruzione, dell'Università e della Ricerca (PRIN 2017WJZ9W9 to MTP).
Copyright:
© 2020 The Authors.
PY - 2020/12/3
Y1 - 2020/12/3
N2 - Knowledge of a protein’s spatial dynamics at the subcellular level is key to understanding its function(s), interactions, and associated intracellular events. Indoleamine 2,3-dioxygenase 1 (IDO1) is a cytosolic enzyme that controls immune responses via tryptophan metabolism, mainly through its enzymic activity. When phosphorylated, however, IDO1 acts as a signaling molecule in plasmacytoid dendritic cells (pDCs), thus activating genomic effects, ultimately leading to long-lasting immunosuppression. Whether the two activities—namely, the catalytic and signaling functions—are spatially segregated has been unclear. We found that, under conditions favoring signaling rather than catabolic events, IDO1 shifts from the cytosol to early endosomes. The event requires interaction with class IA phosphoinositide 3-kinases (PI3Ks), which become activated, resulting in full expression of the immunoregulatory phenotype in vivo in pDCs as resulting from IDO1-dependent signaling events. Thus, IDO1’s spatial dynamics meet the needs for short-acting as well as durable mechanisms of immune suppression, both under acute and chronic inflammatory conditions. These data expand the theoretical basis for an IDO1-centered therapy in inflammation and autoimmunity.
AB - Knowledge of a protein’s spatial dynamics at the subcellular level is key to understanding its function(s), interactions, and associated intracellular events. Indoleamine 2,3-dioxygenase 1 (IDO1) is a cytosolic enzyme that controls immune responses via tryptophan metabolism, mainly through its enzymic activity. When phosphorylated, however, IDO1 acts as a signaling molecule in plasmacytoid dendritic cells (pDCs), thus activating genomic effects, ultimately leading to long-lasting immunosuppression. Whether the two activities—namely, the catalytic and signaling functions—are spatially segregated has been unclear. We found that, under conditions favoring signaling rather than catabolic events, IDO1 shifts from the cytosol to early endosomes. The event requires interaction with class IA phosphoinositide 3-kinases (PI3Ks), which become activated, resulting in full expression of the immunoregulatory phenotype in vivo in pDCs as resulting from IDO1-dependent signaling events. Thus, IDO1’s spatial dynamics meet the needs for short-acting as well as durable mechanisms of immune suppression, both under acute and chronic inflammatory conditions. These data expand the theoretical basis for an IDO1-centered therapy in inflammation and autoimmunity.
KW - dendritic cells
KW - early endosomes
KW - indoleamine 2,3-dioxygenase 1 (IDO1)
KW - phosphoinositide 3-kinase (PI3K)
KW - tryptophan metabolism
UR - http://www.scopus.com/inward/record.url?scp=85096774398&partnerID=8YFLogxK
U2 - 10.15252/embr.201949756
DO - 10.15252/embr.201949756
M3 - Article
C2 - 33159421
AN - SCOPUS:85096774398
SN - 1469-221X
VL - 21
JO - EMBO Reports
JF - EMBO Reports
IS - 12
M1 - e49756
ER -